The FDA is set to review Pfizer’s coronavirus vaccine for kids 5- to 11-years old

Hello,

Welcome to Insider Healthcare. I’m healthcare editor Leah Rosenbaum, and today in healthcare news:


If you’re new to this newsletter, sign up here. Comments, tips? Email me at [email protected] or tweet @leah_rosenbaum. Let’s get to it…


A boy receives the first dose of the Pfizer/BioNTech COVID-19 vaccine in Tegucigalpa, on September 25, 2021, during a vaccination programme for teens aged 12 to 15
A boy receives the first dose of the Pfizer/BioNTech COVID-19 vaccine in Tegucigalpa, on September 25, 2021. ORLANDO SIERRA / AFP) (Photo by ORLANDO SIERRA/AFP/Getty Images

The Pfizer-BioNTech COVID-19 vaccine is 91% effective in 5- to 11-year-olds, new study results find

See the full story>>


A headshot of Dan Mendelson
Dan Mendelson, Morgan Health’s CEO. JPMorgan

The head of JPMorgan’s new health bet reveals the 3 decisions that persuaded him to come aboard even after the bank’s previous venture flopped

Check it out>>


A customer buys onions at the 'Central de Abasto' wholesale market in Mexico City on January 14, 2019. - Some 500,000 people and 62,000 vehicles a day visit the Central de Abasto market on the east side of Mexico City to buy and sell avocados, tomatoes and about 15,000 other products.
A customer buys onions at the ‘Central de Abasto’ wholesale market in Mexico City on January 14, 2019. ALFREDO ESTRELLA / AFP) (Photo credit should read ALFREDO ESTRELLA/AFP/Getty Images

Salmonella linked to onions has infected more than 650 people in 37 states, CDC says

Read more now>>


More stories we’re reading:


-Leah